Evidence map›Paper›PMID 38903717›Full record

ArticleFrontiers in oncology2024

Performance of

Joshua R Menke, Umut Aypar, Charles D Bangs, Stephen L Cook, Srishti Gupta, Robert P Hasserjian, Christina S Kong, Oscar Lin, Steven R Long, Amy Ly and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Joshua R MenkeDivision of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.
Umut AyparDivision of Cytogenetics, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Charles D BangsDivision of Cytogenetics, Department of Pathology, Stanford University, Stanford, CA, United States.
Stephen L CookDepartment of Laboratory Medicine, San Francisco Veterans Administration Health Care System, San Francisco, CA, United States.
Srishti GuptaDivision of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.
Robert P HasserjianDivision of Hematopathology, Department of Pathology, Massachusetts General Hospital, Boston, MA, United States.
Christina S KongDivision of Cytopathology, Department of Pathology, Stanford University, Stanford, CA, United States.
Oscar LinDivision of Cytopathology, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Steven R LongDivision of Cytopathology, Department of Pathology, University of California, San Francisco, San Francisco, CA, United States.
Amy LyDivision of Cytopathology, Department of Pathology, Massachusetts General Hospital, Boston, MA, United States.
Jacob A S MenkeSenior Backend Engineer, Big Nerd Ranch, Atlanta, GA, United States.
Yasodha NatkunamDivision of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.
Roberto Ruiz-CorderoDivision of Cytopathology, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Elizabeth SpiteriDivision of Cytogenetics, Department of Pathology, Stanford University, Stanford, CA, United States.
Julia YeDivision of Cytopathology, Department of Pathology, University of California, San Francisco, San Francisco, CA, United States.
Sara L ZadehDivision of Cytopathology, Department of Pathology, University of Virginia, Charlottesville, VA, United States.
Dita A GratzingerDivision of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Introduction: Fluorescence Methods: We describe the results of Results: FISH had a low hybridization failure rate of around 1% across all specimen types. FISH identified concurrent Discussion: FISH showed a similar hybridization failure rate in all biopsy types. Ultimately,

Indexed as

BCL2 rearrangementdiffuse large B-cell lymphomadouble-hit lymphomaFISHhigh-grade B-cell lymphomaMYC rearrangement

Identifiers

PMID38903717
PMCPMC11187077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.